Sponsor:
Jordan Feld
Code:
NCT04620226
Conditions
Hepatitis C
Hepatitis B
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Quality Improvement
Brief summary:
Conditions
Hepatitis C
Hepatitis B
Study ID
NCT04620226
Start date
Feb 1, 2024
Status verified date
Feb, 2024
Completion date
Jul, 2025
Anticipated
Primary completion date
Jul, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
2920 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Screening
Arms
no intervention: Conventional Serum Testing
experimental: Rapid Point-of-Care Testing
Interventions
Quality Improvement
Primary outcome measure
Central contacts
Locations
Toronto General Hospital
Recruiting
Toronto, Ontario, Canada, M5G 2C4
Toronto Western Hospital
Recruiting
Toronto, Ontario, Canada, M5T 2S8
Sponsor
Jordan Feld
Last update posted
Feb 8, 2024
Last verified
Feb, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Jordan Feld on 2024-02-08.